Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Population Health

Total Results:

12703


Urologist-led smoking cessation: a way forward through implementation science [Editorial]

Matulewicz, Richard S; Makarov, Danil V; Sherman, Scott E; Birken, Sarah A; Bjurlin, Marc A
PMCID:7844518
PMID: 33532289
ISSN: 2223-4691
CID: 4799642

Multi-Level Predictors of Discharges Against Medical Advice: Identifying Contributors to Variation Using an All-Payer Database

Onukwugha, Eberechukwu; Nagarajan, Madhu; Offurum, Ada; Gulati, Mangla; Alfandre, David
ABSTRACT/UNASSIGNED:There is increasing evidence of the role of non-patient-level factors on discharge against medical advice (DAMA), but limited quantitative information regarding the extent of their impact. This study quantifies the contribution of discharge-level and hospital-level factors to the variation in DAMA. We grouped variables from the 2014 National Inpatient Sample data and ran incremental mixed-effects logit models with grouping at the level of the discharge, the hospital, and the census region. We obtained the intraclass correlation coefficients (ICCs), and evaluated the incremental change in ICC. The final sample included 2,687,430 discharges. 12.8% of the identified variation in the probability of DAMA was associated with the hospital, and 1.2% of the variation was associated with the census division in which the hospital was located. The final, fully-adjusted model had 7.3% of variation in DAMA associated with the hospital-level, with the greatest percentage reductions because of the addition of patient demographics. Even after adjusting for measured patient-level characteristics, there was a contribution of non-patient-level factors to DAMA outcomes. The findings identify a role for a multi-level approach to addressing DAMA.
PMID: 32134810
ISSN: 1945-1474
CID: 4774092

Associations of changes in fat free mass with risk for type 2 diabetes: Hispanic Community Health Study/Study of Latinos

LeCroy, M N; Hua, S; Kaplan, R C; Sotres-Alvarez, D; Qi, Q; Thyagarajan, B; Gallo, L C; Pirzada, A; Daviglus, M L; Schneiderman, N; Talavera, G A; Isasi, C R
AIMS/OBJECTIVE:To determine whether loss of muscle mass (approximated using fat free mass [FFM]) is associated with risk for type 2 diabetes mellitus (T2DM) in Hispanic/Latino adults in the United States. METHODS:Participants were Hispanic/Latino adults (18-74-year-olds) who completed Visit 2 of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL; multi-site, prospective cohort study; 6.1-year follow-up) and did not have T2DM at baseline (n = 6264). At baseline and Visit 2, FFM was measured using bioelectrical impedance analysis and fasting glucose, HbA1c, and fasting insulin were measured by examiners. Diabetes was defined according to American Diabetes Association criteria. Survey-weighted Poisson regression models examined the association of percent change in relative FFM (%ΔFFM) with incident prediabetes and T2DM. Survey-weighted multivariable regression models examined associations of %ΔFFM with changes in glucose and insulin measures. RESULTS:Relative FFM declined by 2.1% between visits. %ΔFFM was inversely associated with incident prediabetes (p-for-trend = 0.001) and with changes in glucose and insulin measures (p-for-trend <0.0001). Findings were null, except for HOMA-IR, after adjustment for changes in adiposity measures. Associations were generally stronger for individuals with baseline overweight/obesity. CONCLUSIONS:Reducing loss of FFM during adulthood may reduce prediabetes risk (primarily insulin resistance), particularly among individuals with overweight/obesity.
PMCID:8425264
PMID: 33242517
ISSN: 1872-8227
CID: 5149782

Global Survey of the Roles and Attitudes Towards Social Media Platforms Amongst Urology Trainees

Dubin, Justin M; Greer, Aubrey B; Patel, Premal; Carrion, Diego M; Paesano, Nahuel; Kettache, Reda H; Haffaf, Malik; Zouari, Skander; Santillan, Diego; Zotter, Zsuzsanna; Chung, Amanda; Horie, Shigeo; Koo, Kyo Chul; Teoh, Jeremy Yc; Gómez, Ana Maria Autrán; Ramasamy, Ranjith; Loeb, Stacy; Rivas, Juan Gomez
OBJECTIVES/OBJECTIVE:To perform a global survey assessing the role of and the attitudes towards media platforms amongst training Urologists METHODS: We distributed a 21-item online survey on social medial (SoMe) and other media platforms to current Urology trainees by email via individual institutions and multiple Urological associations. The survey acquired data including baseline characteristics, the role of and attitudes towards SoMe and other media platforms in training and assessed the prevalence of Social Media Disorder (SMD) based on the validated 9-item Social Media Disorder Scale. Stata IC was used for statistical analysis. RESULTS:Three hundred and seventy-two urology trainees in 6 continents participated in the survey. Overall, 99.4% used SoMe and 27.3% listened to healthcare-focused podcasts. Most trainees (85.5%) are using guideline apps for education purposes, with the top 3 most utilized apps being the EAU, AUA, and UpToDate applications. There was mixed sentiment regarding the impact of SoMe on the patient-physician relationship, wherein most felt it challenges the doctor's authority (56.7%) but also empowers the patient (62.7%) and encourages shared-care (57.3%). Unfortunately, 11.3% of urology trainees met criteria for SMD while 65.4% had not reviewed professional guidelines on appropriate SoMe use. CONCLUSIONS:Despite practically all urology trainees using SoMe and guideline applications, the majority of trainees have not reviewed or have been educated on professional guidelines for SoMe usage. There is a small but significant number of trainees who are at risk for social media disorder which may be contributing to higher rates of physician burnout amongst urologists.
PMID: 32950594
ISSN: 1527-9995
CID: 4593962

The Steroid Metabolome and Breast Cancer Risk in Women with a Family History of Breast Cancer: The Novel Role of Adrenal Androgens and Glucocorticoids

Houghton, Lauren C; Howland, Renata E; Wei, Ying; Ma, Xinran; Kehm, Rebecca D; Chung, Wendy K; Genkinger, Jeanine M; Santella, Regina M; Hartmann, Michaela F; Wudy, Stefan A; Terry, Mary Beth
BACKGROUND:No study has comprehensively examined how the steroid metabolome is associated with breast cancer risk in women with familial risk. METHODS:We examined 36 steroid metabolites across the spectrum of familial risk (5-year risk ranged from 0.14% to 23.8%) in pre- and postmenopausal women participating in the New York site of the Breast Cancer Family Registry (BCFR). We conducted a nested case-control study with 62 cases/124 controls individually matched on menopausal status, age, and race. We measured metabolites using GC-MS in urine samples collected at baseline before the onset of prospectively ascertained cases. We used conditional logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) per doubling in hormone levels. RESULTS:The average proportion of total steroid metabolites in the study sample were glucocorticoids (61%), androgens (26%), progestogens (11%), and estrogens (2%). A doubling in glucocorticoids (aOR = 2.7; 95% CI = 1.3-5.3) and androgens (aOR = 1.6; 95% CI = 1.0-2.7) was associated with increased breast cancer risk. Specific glucocorticoids (THE, THF αTHF, 6β-OH-F, THA, and α-THB) were associated with 49% to 161% increased risk. Two androgen metabolites (AN and 11-OH-AN) were associated with 70% (aOR = 1.7; 95% CI = 1.1-2.7) and 90% (aOR = 1.9; 95% CI = 1.2-3.1) increased risk, respectively. One intermediate metabolite of a cortisol precursor (THS) was associated with 65% (OR = 1.65; 95% CI = 1.0-2.7) increased risk. E1 and E2 estrogens were associated with 20% and 27% decreased risk, respectively. CONCLUSIONS:Results suggest that glucocorticoids and 11-oxygenated androgens are positively associated with breast cancer risk across the familial risk spectrum. IMPACT:If replicated, our findings suggest great potential of including steroids into existing breast cancer risk assessment tools.
PMCID:7855281
PMID: 32998947
ISSN: 1538-7755
CID: 5774252

A Taxonomy for External Support for Practice Transformation

Solberg, Leif I; Kuzel, Anton; Parchman, Michael L; Shelley, Donna R; Dickinson, W Perry; Walunas, Theresa L; Nguyen, Ann M; Fagnan, Lyle J; Cykert, Samuel; Cohen, Deborah J; Balasubramanaian, Bijal A; Fernald, Douglas; Gordon, Leah; Kho, Abel; Krist, Alex; Miller, William; Berry, Carolyn; Duffy, Daniel; Nagykaldi, Zsolt
BACKGROUND:There is no commonly accepted comprehensive framework for describing the practical specifics of external support for practice change. Our goal was to develop such a taxonomy that could be used by both external groups or researchers and health care leaders. METHODS:The leaders of 8 grants from Agency for Research and Quality for the EvidenceNOW study of improving cardiovascular preventive services in over 1500 primary care practices nationwide worked collaboratively over 18 months to develop descriptions of key domains that might comprehensively characterize any external support intervention. Combining literature reviews with our practical experiences in this initiative and past work, we aimed to define these domains and recommend measures for them. RESULTS:The taxonomy includes 1 domain to specify the conceptual model(s) on which an intervention is built and another to specify the types of support strategies used. Another 5 domains provide specifics about the dose/mode of that support, the types of change process and care process changes that are encouraged, and the degree to which the strategies are prescriptive and standardized. A model was created to illustrate how the domains fit together and how they would respond to practice needs and reactions. CONCLUSIONS:This taxonomy and its use in more consistently documenting and characterizing external support interventions should facilitate communication and synergies between 3 areas (quality improvement, practice change research, and implementation science) that have historically tended to work independently. The taxonomy was designed to be as useful for practices or health systems managing change as it is for research.
PMID: 33452080
ISSN: 1558-7118
CID: 4798682

A View from the past into our collective future: the oncofertility consortium vision statement

Woodruff, Teresa K; Ataman-Millhouse, Lauren; Acharya, Kelly S; Almeida-Santos, Teresa; Anazodo, Antoinette; Anderson, Richard A; Appiah, Leslie; Bader, Joy; Becktell, Kerri; Brannigan, Robert E; Breech, Lesley; Bourlon, Maria T; Bumbuliene, Žana; Burns, Karen; Campo-Engelstein, Lisa; Campos, Jacira R; Centola, Grace M; Chehin, Mauricio Barbour; Chen, Diane; De Vos, Michel; Duncan, Francesca E; El-Damen, Ahmed; Fair, Douglas; Famuyiwa, Yemi; Fechner, Patricia Y; Fontoura, Paula; Frias, Olivia; Gerkowicz, Sabrina A; Ginsberg, Jill; Gracia, Clarisa R; Goldman, Kara; Gomez-Lobo, Veronica; Hazelrigg, Brent; Hsieh, Michael H; Hoyos, Luis R; Hoyos-Martinez, Alfonso; Jach, Robert; Jassem, Jacek; Javed, Murid; Jayasinghe, Yasmin; Jeelani, Roohi; Jeruss, Jacqueline S; Kaul-Mahajan, Nalini; Keim-Malpass, Jessica; Ketterl, Tyler G; Khrouf, Mohamed; Kimelman, Dana; Kusuhara, Atsuko; Kutteh, William H; Laronda, Monica M; Lee, Jung Ryeol; Lehmann, Vicky; Letourneau, Joseph M; McGinnis, Lynda K; McMahon, Eileen; Meacham, Lillian R; Mijangos, Monserrat Fabiola Velez; Moravek, Molly; Nahata, Leena; Ogweno, George Moses; Orwig, Kyle E; Pavone, Mary Ellen; Peccatori, Fedro Alessandro; Pesce, Romina Ileana; Pulaski, Hanna; Quinn, Gwendolyn; Quintana, Ramiro; Quintana, Tomas; de Carvalho, Bruno Ramalho; Ramsey-Goldman, Rosalind; Reinecke, Joyce; Reis, Fernando M; Rios, Julie; Rhoton-Vlasak, Alice S; Rodriguez-Wallberg, Kenny A; Roeca, Cassandra; Rotz, Seth J; Rowell, Erin; Salama, Mahmoud; Saraf, Amanda J; Scarella, Anibal; Schafer-Kalkhoff, Tara; Schmidt, Deb; Senapati, Suneeta; Shah, Divya; Shikanov, Ariella; Shnorhavorian, Margarett; Skiles, Jodi L; Smith, James F; Smith, Kristin; Sobral, Fabio; Stimpert, Kyle; Su, H Irene; Sugimoto, Kouhei; Suzuki, Nao; Thakur, Mili; Victorson, David; Viale, Luz; Vitek, Wendy; Wallace, W Hamish; Wartella, Ellen A; Westphal, Lynn M; Whiteside, Stacy; Wilcox, Lea H; Wyns, Christine; Xiao, Shuo; Xu, Jing; Zelinski, Mary
PURPOSE/OBJECTIVE:Today, male and female adult and pediatric cancer patients, individuals transitioning between gender identities, and other individuals facing health extending but fertility limiting treatments can look forward to a fertile future. This is, in part, due to the work of members associated with the Oncofertility Consortium. METHODS:The Oncofertility Consortium is an international, interdisciplinary initiative originally designed to explore the urgent unmet need associated with the reproductive future of cancer survivors. As the strategies for fertility management were invented, developed or applied, the individuals for who the program offered hope, similarly expanded. As a community of practice, Consortium participants share information in an open and rapid manner to addresses the complex health care and quality-of-life issues of cancer, transgender and other patients. To ensure that the organization remains contemporary to the needs of the community, the field designed a fully inclusive mechanism for strategic planning and here present the findings of this process. RESULTS:This interprofessional network of medical specialists, scientists, and scholars in the law, medical ethics, religious studies and other disciplines associated with human interventions, explore the relationships between health, disease, survivorship, treatment, gender and reproductive longevity. CONCLUSION/CONCLUSIONS:The goals are to continually integrate the best science in the service of the needs of patients and build a community of care that is ready for the challenges of the field in the future.
PMCID:7786868
PMID: 33405006
ISSN: 1573-7330
CID: 4771062

Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation

Raynaud, Marc; Aubert, Olivier; Reese, Peter P; Bouatou, Yassine; Naesens, Maarten; Kamar, Nassim; Bailly, Élodie; Giral, Magali; Ladrière, Marc; Le Quintrec, Moglie; Delahousse, Michel; Juric, Ivana; Basic-Jukic, Nikolina; Gupta, Gaurav; Akalin, Enver; Yoo, Daniel; Chin, Chen-Shan; Proust-Lima, Cécile; Böhmig, Georg; Oberbauer, Rainer; Stegall, Mark D; Bentall, Andrew J; Jordan, Stanley C; Huang, Edmund; Glotz, Denis; Legendre, Christophe; Montgomery, Robert A; Segev, Dorry L; Empana, Jean-Philippe; Grams, Morgan E; Coresh, Josef; Jouven, Xavier; Lefaucheur, Carmen; Loupy, Alexandre
Although the gold standard of monitoring kidney transplant function relies on glomerular filtration rate (GFR), little is known about GFR trajectories after transplantation, their determinants, and their association with outcomes. To evaluate these parameters we examined kidney transplant recipients receiving care at 15 academic centers. Patients underwent prospective monitoring of estimated GFR (eGFR) measurements, with assessment of clinical, functional, histological and immunological parameters. Additional validation took place in seven randomized controlled trials that included a total of 14,132 patients with 403,497 eGFR measurements. After a median follow-up of 6.5 years, 1,688 patients developed end-stage kidney disease. Using unsupervised latent class mixed models, we identified eight distinct eGFR trajectories. Multinomial regression models identified seven significant determinants of eGFR trajectories including donor age, eGFR, proteinuria, and several significant histological features: graft scarring, graft interstitial inflammation and tubulitis, microcirculation inflammation, and circulating anti-HLA donor specific antibodies. The eGFR trajectories were associated with progression to end stage kidney disease. These trajectories, their determinants and respective associations with end stage kidney disease were similar across cohorts, as well as in diverse clinical scenarios, therapeutic eras and in the seven randomized control trials. Thus, our results provide the basis for a trajectory-based assessment of kidney transplant patients for risk stratification and monitoring.
PMID: 32781106
ISSN: 1523-1755
CID: 4756732

Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia

,; Smith, Michael D; Fee, Christopher; Mace, Sharon E; Maughan, Brandon; Perkins, John C; Kaji, Amy; Wolf, Stephen J
This clinical policy from the American College of Emergency Physicians is a revision of the 2009 "Clinical Policy: Critical Issues in the Management of Adult Patients Presenting to the Emergency Department With Community-Acquired Pneumonia." A writing subcommittee conducted a systematic review of the literature to derive evidence-based recommendations to answer the following clinical questions: (1) In the adult emergency department patient diagnosed with community-acquired pneumonia, what clinical decision aids can inform the determination of patient disposition? (2) In the adult emergency department patient with community-acquired pneumonia, what biomarkers can be used to direct initial antimicrobial therapy? (3) In the adult emergency department patient diagnosed with community-acquired pneumonia, does a single dose of parenteral antibiotics in the emergency department followed by oral treatment versus oral treatment alone improve outcomes? Evidence was graded and recommendations were made based on the strength of the available data.
PMID: 33349374
ISSN: 1097-6760
CID: 5953312

Shifts in Unintentional Exposure to Drugs Among People Who Use Ecstasy in the Electronic Dance Music Scene, 2016-2019

Palamar, Joseph J; Salomone, Alberto
BACKGROUND AND OBJECTIVES/OBJECTIVE:Electronic dance music (EDM) party attendees who use ecstasy (3,4-methylenedioxymethamphetamine [MDMA], Molly) are at high risk for ingesting adulterant drugs, but little is known regarding trends in exposure. We sought to determine whether adulteration has shifted in recent years. METHODS:Adults entering EDM events at nightclubs and dance festivals in NYC were surveyed in 2016 and 2019. We tested hair samples from a subsample of those reporting past-year ecstasy use using ultra-high performance liquid chromatography-tandem mass spectrometry. Differences in unreported drug exposure and suspected adulteration were compared between 2016 (n = 90) and 2019 (n = 72). RESULTS:MDMA detection was stable at 72-74%. We detected decreases in unreported use of methamphetamine (from 22.2% to 5.6% [P = .003], an 74.8% decrease), new psychoactive substances (from 31.1% to 2.8% [P < .001], a 91.0% decrease), and synthetic cathinones in particular (from 27.8% to 2.8% (P < .001, an 89.9% decrease). Unreported ketamine exposure increased from 18.9% to 34.7% (P = .022, an 83.6% increase). We also detected decreases in participants' suspicion of their ecstasy being adulterated with methamphetamine (from 20.0% to 5.6% [P = .010], an 72.0% decrease) and "bath salts" (synthetic cathinones, from 8.9% to 1.4% [P = .044], an 84.3% decrease). DISCUSSION AND CONCLUSIONS/CONCLUSIONS:Unknown exposure to adulterants among people who use ecstasy in the EDM scene is shifting. Monitoring of exposure to adulterants is needed to inform harm reduction. SCIENTIFIC SIGNIFICANCE/CONCLUSIONS:This was among the first studies to examine unintentional exposure to drugs over time in this population and unintentional exposure to synthetic cathinones in particular appears to be declining. (Am J Addict 2020;00:00-00).
PMID: 32813326
ISSN: 1521-0391
CID: 4565642